Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Wednesday, September 9, 2026

Snapshot: Sep 9, 2026 · 6:00 PM 100 stocks analyzed

Flat Day

Wed, Sep 9, 2026 Divergent Normal

Broad flat tape masked sharp divergence as healthcare led a 35% gainer concentration while financials and industrials bore outsized losses, pushing VIX up 15% despite stable hea…

50% A divergent market with opposing forces—SPY essentially flat (+0.06%) while NASDAQ 100 surged 1.18%, the Dow dropped 0.73%, and small caps (Russell 2000) barely moved—left direction ambiguous even as fear spiked with a 15% VIX jump and normal dispersion (50 gainers averaging +24.9%, 50 losers averaging -20.9%).
30% Healthcare commanded 35% of gainers but also 26% of losers, signaling sector-wide volatility; news-grounded winners like UFG (+61.7% on record H1 results), BURUD (+35.5% on trading reinstatement), and SIG (+23.7% on earnings beat) sat alongside unexplained mega-movers like FTFT (+100%) and YMAT (+70.5%), suggesting micro-cap speculation amid broader unease.
20% Persistent gainers (GSRFR on a 4-day winning streak) and a debutant wave of five names re-entering the top 50 after absences pointed to stock-pickers hunting for arbitrage and technical resets, while major losers like CRMT (-41.6% on revenue collapse) and AACI (-77% with no news) drove the outsized negative tail despite index stability.

Healthcare drove 35% of gainers 5 names returned after long absences GSRFR · 4-day gainers streak TRBG · 3-day losers streak BURUD — first appearance SIG — first appearance

Market Regime

Wed, Sep 9, 2026 Neutral conf: medium macro · prototype

-7

Neutral −100 … +100 · + tailwind / − headwind

VIX16.5 p48 Drawdown-2.1% Held3d · building SinceSep 7

Top drivers: Small-cap leadership ▼ S&P drawdown (60d) ▲ VIX 5d momentum ▼

processId: history-market-regime

Market Indexes

Wed, Sep 9, 2026 13

S&P 500

7,636.36

+4.89

+0.06%

Dow Jones

52,380.66

−386.22

-0.73%

NASDAQ Composite

26,253.34

+153.57

+0.59%

NASDAQ 100

29,421.55

+344.33

+1.18%

DJ US Total Market

75,477.27

+63.10

+0.08%

Russell 1000

4,157.26

+2.59

+0.06%

S&P MidCap 400

3,718.46

−2.33

-0.06%

Russell 2000

2,921.23

+1.10

+0.04%

Russell 2500

1,246.60

−15.71

-1.24%

Russell 3000

4,336.48

+2.67

+0.06%

Nasdaq Financial-100

7,604.29

−98.02

-1.27%

NIFTY 50

23,431.50

−441.95

-1.85%

VIX

16.46

+2.14

+14.94%

Biggest Gainers

Wed, Sep 9, 2026 50

FTFT

Future FinTech Group IncTechnology

$2.07+$1.29

+100.0%

NASDAQ · Mkt cap $1.8 M

No news headlines were found in the last 48 hours, so the 100% price jump on FTFT cannot be attributed to a specific announced catalyst. The move is likely driven by technical factors, market rumors, or delayed information.

Yahoo Finance returned no headlines for Future FinTech Group in the 48 hours preceding this snapshot. A stock doubling in a single day without contemporaneous news coverage is unusual and suggests one of several non-news-based drivers: a technical squeeze or reversal in a thinly traded microcap, execution of a previously announced but not widely followed corporate action, social media momentum or retail attention, or market reaction to news that has not yet been indexed by major financial news aggregators. Microcap and small-cap stocks like FTFT are prone to sharp moves on low volume and can experience significant reversals without fundamental catalysts. Without access to real-time volume, short interest data, or company filings released that day, the specific trigger remains unknown.

YMAT

J-STAR HOLDING CO LTDBasic Materials

$2.29+$0.91

+70.5%

NASDAQ · Mkt cap $7.3 M

No news headlines were available in the last 48 hours to explain YMAT's 70.54% surge on September 9, 2026, so the catalyst remains unidentified from public reporting sources.

The absence of recent news in the Yahoo Finance RSS feed means we cannot point to a specific earnings release, product announcement, regulatory decision, or corporate action as the cause of this sharp rally. For a company trading on NASDAQ at this price level with this kind of explosive single-day move and no corresponding headline coverage, the most likely explanations fall into a few categories: delayed or after-hours news not yet indexed by major news feeds, a technical bounce or short squeeze in a thinly traded name, insider activity, or unconfirmed market rumors circulating on social media or specialist trading channels. Without access to real-time trading data, regulatory filings, or verification from official company sources, we cannot distinguish among these possibilities. The rank as the 2 biggest gainer suggests meaningful volume, but without headline support this remains speculative.

SNYR

Synergy CHC Corp.Healthcare

$0.08+$0.06

+69.2%

NASDAQ · Mkt cap $1.6 M

No news headlines about SNYR itself were provided; the 69% gain is unexplained by the available evidence, though micro-cap stocks often exhibit volatile moves on speculative activity or delayed news.

The only headline supplied concerns InnovAge (INNV), a separate company, and contains no mention of SNYR or Synergy CHC Corp. Therefore the news provided does not establish a direct cause for the jump. SNYR is a micro-cap stock trading at $0.08, a category historically prone to large single-day percentage moves driven by retail speculation, short covering, or delayed disclosure of material news not yet reflected in major financial feeds. Without specific information about SNYR's business, recent announcements, or market structure, plausible categories include technical oversold conditions, social media momentum, pending corporate actions, or unconfirmed rumors. The timing and magnitude of the move cannot be explained by the evidence at hand.

UFG

Uni-Fuels Holdings LimitedIndustrials

$0.73+$0.34

+61.7%

NASDAQ · Mkt cap $19 M

Uni-Fuels reported record first-half 2026 results with 72% revenue growth, 598% EBITDA growth, and raised full-year guidance to $340M-$360M, directly triggering the +61.73% single-day rally.

The company announced substantially stronger than prior performance across nearly every metric announced today. Revenue grew 72% year-over-year to $197.1 million in the first half, gross profit surged 158% to $5.3 million, and EBITDA expanded dramatically 598% to $2.1 million. Operating margin more than quadrupled from 8.9% to 35.8%, signaling improved operational leverage. The full-year guidance raise to $340M-$360M in revenue provides forward visibility and confidence in sustained momentum. For a stock trading at $0.73, which suggests either a micro-cap or severely distressed valuation, this magnitude of operational turnaround and profit acceleration represents the kind of inflection point that can drive explosive single-day moves, especially if the market had been pricing in continued weakness or losses.

WTER

Alkaline Water Co Inc-TheConsumer Defensive

$0.02+$0.01

+49.1%

NASDAQ · Mkt cap $1.1 M

No news headlines were found in the last 48 hours, so the 49% gain on WTER is unexplained by reported events; the move likely reflects technical trading, short covering, or untracked social media discussion.

WTER showed a significant 49% single-day gain on September 9, 2026, yet no news headlines appear in the Yahoo Finance RSS feed for the preceding 48 hours. This absence of news is itself important: it rules out major announced catalysts such as earnings releases, FDA approvals, product launches, or strategic partnerships as documented drivers. For a micro-cap stock trading at $0.02, price moves of this magnitude often occur in low-liquidity environments where small absolute dollar volumes can create large percentage swings. Two plausible explanations, neither confirmed by the evidence provided, are short squeeze activity—in which a heavily shorted stock rebounds as holders cover positions—or retail or thematic trader attention driven by social media or message boards rather than newswire outlets. Without access to volume data, short interest, or broader market context, we cannot distinguish between these scenarios.

IRHOR

Iron Horse Acquisitions Corp. II Rights

$0.20+$0.06

+42.3%

NASDAQ

No headlines were published in the last 48 hours to explain the 42.35% gain in IRHOR rights. The jump likely reflects technical activity, a delayed reaction to prior news, or market sentiment around the underlying SPAC merger process.

IRHOR is a blank-check company rights offering, a structure that typically exhibits high volatility and can move sharply on developments related to the merger target, deal timeline, or investor sentiment toward the combination. The absence of any recent news headlines within the 48-hour window means the catalyst is not immediately apparent from public reporting. Possible explanations include a delayed market reaction to an announcement from the prior week, technical trading or short covering in a thinly traded rights instrument, retail investor interest, or internal company communication not yet reflected in major news feeds. Rights offerings are also prone to speculative moves around deal certainty or valuation shifts.

BURUD

NUBURU INC

$1.68+$0.44

+35.5%

IRD

Opus Genetics, Inc.Healthcare

$5.72+$1.48

+33.0%

NASDAQ · Mkt cap $302 M

Opus Genetics announced positive Phase 1/2 trial data for OPGx-BEST1 showing clinically meaningful improvements in visual function and favorable safety, plus FDA alignment on a Phase 3 pathway, driving a +33% rally on September 9th.

The stock's strong gain directly tracks the company's announcement of positive low-dose Cohort 1 data from the BIRD-1 Phase 1/2 trial of OPGx-BEST1. All five trial participants demonstrated clinically meaningful improvement in visual function with no serious adverse events or dose-limiting toxicities observed. Four of five patients showed structural retinal improvements. The company also reported successful alignment with the FDA on potential pivotal endpoints and a development timeline targeting Phase 3 dosing in 2027. For a clinical-stage biotech company focused on retinal diseases, positive safety and efficacy signals from early trials combined with regulatory clarity on the path to pivotal studies represent a meaningful derisking event. The late-afternoon healthcare sector softness noted in one headline does not appear to have dampened the stock's momentum, suggesting the IRD-specific news overwhelmed any sector headwinds.

GELS

Gelteq Limited Ordinary SharesHealthcare

$0.85+$0.21

+32.7%

NASDAQ · Mkt cap $6.0 M

No news headlines were found in the last 48 hours, so the 32.74% intraday jump on GELS appears driven by technical factors, short covering, or undisclosed information rather than a reported catalyst.

The absence of any Yahoo Finance headlines in the 48-hour window before this significant gain makes it difficult to pinpoint a specific corporate or market event as the cause. A 33% single-day move in a low-priced micro-cap stock like GELS ($0.85) is notable but not unusual for securities with thin trading liquidity and small market capitalizations. Possible drivers could include short squeeze activity if the stock had elevated short interest, a technical breakout drawing retail attention, delayed disclosure or rumor-driven trading, or an announcement made through channels not yet indexed by the headline feed. Without access to intraday order flow, insider trading filings, or company press releases issued outside standard news wires, the mechanism remains speculative.

ALISR

Calisa Acquisition Corp Right

$0.75+$0.17

+29.3%

NASDAQ

No headlines are available in the past 48 hours, but ALISR is a SPAC rights unit that may have moved on technical factors, warrant conversion dynamics, or delayed news absorption rather than a specific announced catalyst.

The absence of recent news makes the 29% intraday jump difficult to attribute to a discrete company event. However, ALISR (Calisa Acquisition Corp Right) is a SPAC-related security, and rights units can experience sharp moves on technical factors including warrant redemption dynamics, proxy vote developments, merger timeline updates, or changes in the underlying SPAC's trading momentum, even without simultaneous news coverage. The magnitude of the gain and its ranking as a top-10 mover suggests real trading activity rather than a micro-cap anomaly. Without headline confirmation, the most likely categories are: delayed market reaction to an older announcement, technical or options-driven positioning, or a development not yet captured in financial news feeds. The structural thinness of SPAC rights units also makes them susceptible to modest volume shifts that produce outsized percentage moves.

ODD

ODDITY Tech Ltd. - Class A Ordinary SharesConsumer Defensive

$16.50+$3.74

+28.8%

NASDAQ · Mkt cap $738 M

ODD surged 28.77% after beating Q2 earnings and revenue expectations while raising full-year 2026 guidance, despite a 25% year-over-year revenue decline in the quarter itself.

The stock rallied on a classic earnings beat narrative. Multiple headlines confirm that ODDITY Tech posted earnings per share that beat Wall Street estimates by 66.67% and revenue that beat by 3.27% for Q2 2026. More importantly, management raised its full-year 2026 profit outlook, signaling confidence in sequential improvement ahead despite near-term headwinds in the legacy IL MAKIAGE brand. The company reported $181 million in Q2 revenue (down 25% year-over-year), $13 million in net income, and $13 million in adjusted EBITDA. Market participants appear to have focused on the forward guidance raise and earnings beat rather than the backward-looking revenue decline, which is typical when management demonstrates path to recovery. The 14% jump reported in one headline likely refers to intraday trading, with the stock settling at the +28.77% gain by market close.

OceanPal Inc.Industrials

$11.62+$2.55

+28.1%

NASDAQ · Mkt cap $218 M

No news headlines were found in the last 48 hours, so the 28% gain on OP cannot be tied to a specific disclosed catalyst. The jump may reflect technical strength, a delayed market reaction, or undisclosed industry developments.

OceanPal Inc. is a shipping company that operates dry bulk vessels, a cyclical commodity-exposed sector sensitive to macroeconomic shifts and freight rates. The absence of recent news headlines means this 28% single-day surge cannot be attributed to earnings, contract announcements, or corporate actions covered in major feeds. Possible explanations include renewed strength in dry bulk shipping rates or broader commodity market sentiment, a delayed market reaction to older developments, technical or algorithmic trading activity, or undisclosed company-specific news not yet reflected in public feeds. Shipping stocks can exhibit sharp intraday volatility tied to Baltic indices and freight futures, which may have moved favorably without corresponding press releases. Without concrete headline evidence, the specific trigger remains unknown.

BIAF

bioAffinity Technologies, Inc. Healthcare

$10.59+$2.49

+28.1%

NASDAQ · Mkt cap $3.3 M

No news headlines were found in the last 48 hours, so the 28% gain on BIAF is unexplained by reported corporate announcements, earnings, or regulatory actions. The move likely reflects technical or market factors, undisclosed news, or a rumor not yet captured in major financial media.

BioAffinity Technologies is a small-cap diagnostic technology company, and the absence of any headlines in the Yahoo Finance RSS feed over the past two days creates a significant information gap. A 28% single-day jump of this magnitude in a micro-cap stock can stem from several categories: a corporate event announced through channels not yet indexed by major news aggregators, short covering or technical momentum, insider activity, clinical trial results or regulatory developments not yet picked up by mainstream media, or unverified rumors circulating in retail investor channels. Without headlines, we cannot distinguish between these possibilities. Biotech and diagnostic firms are particularly prone to sharp moves on clinical or regulatory milestones, but no such event is documented here.

RIBBR

Ribbon Acquisition Corp Rights

$0.29+$0.06

+24.5%

NASDAQ · Mkt cap $1.2 M

No news headlines were found in the last 48 hours, so the 24.46% gain cannot be attributed to a specific announced catalyst. The move is most likely driven by technical factors, speculative positioning, or delayed news coverage not yet indexed.

Ribbon Acquisition Corp Rights (RIBBR) jumped 24.46% with no corresponding news in the Yahoo Finance RSS feed over the last two days. This is a rights offering tied to a SPAC, a security type that can be sensitive to momentum, changes in redemption expectations, or shifts in investor appetite for the underlying merger or warrant complex. When a SPAC or its related instruments move sharply without visible news, the catalyst is often either a technical rebound after prior weakness, short covering, retail flow attention, or news that has circulated on social media or alternative channels but not yet appeared in major financial news feeds. It is also possible that a material announcement was made but had not yet reached Yahoo Finance's indexing window at the time of this snapshot.

SUNE

Pineapple Energy Inc.Technology

$4.52+$0.76

+24.4%

NASDAQ · Mkt cap $9.2 M

Pineapple Energy (SUNE) surged 24% following news that Suniva completed an $835 million capital raise to build a second major U.S. solar manufacturing facility and quadruple capacity to 5.5 GW, signaling significant growth and expansion in domestic solar production.

The headlines establish that Suniva, described as the largest and oldest U.S. merchant manufacturer of high-efficiency monocrystalline silicon solar cells, closed an $835 million funding round. This capital raise is tied to construction of a second major manufacturing facility and a capacity expansion from current levels to 5.5 GW. The market reaction reflects investor enthusiasm for domestic solar manufacturing capacity growth, which aligns with U.S. policy incentives for on-shoring clean energy production. The premarket move of nearly 26% mentioned in the first headline closely matches the 24.44% closing gain reported here, indicating the capital announcement was the primary driver of the move. No contradictory news or earnings data was provided, so the capital raise announcement appears to be the sole catalyst.

SIG

Signet Jewelers Ltd

$102.41+$19.65

+23.7%

GSRFR

GSR IV Acquisition Corp. Rights

$2.15+$0.41

+23.6%

NASDAQ

No news headlines were found in the last 48 hours, so the 23.56% jump in GSRFR rights shares likely reflects a SPAC-related catalyst such as a merger announcement, shareholder vote approval, or redemption/exercise deadline event that may not yet be widely reported.

GSR IV Acquisition Corp. Rights are equity warrants tied to a blank-check company, and such securities are highly sensitive to SPAC merger catalysts, shareholder votes, and redemption dynamics. The absence of headlines in Yahoo Finance's feed does not mean no catalyst occurred; SPAC announcements often drive large single-day moves in rights and warrants ahead of broad press coverage. Common triggers include merger agreement announcements, proxy vote results, exercise deadlines, or redemption thresholds. Rights typically rise when the underlying SPAC stock jumps on positive merger news or when exercise windows approach. Without confirmation from the news sources provided, the exact catalyst cannot be identified, but this magnitude of move is consistent with SPAC-related corporate action rather than general market momentum.

EONR.WT

EON Resources Inc WT

$0.09+$0.02

+23.3%

OYSER

Oyster Enterprises II Acquisition Corp Rights

$0.14+$0.02

+21.6%

GLMD

Galmed Pharmaceuticals LtdHealthcare

$4.60+$0.80

+21.1%

NASDAQ · Mkt cap $4.2 M

Galmed Pharmaceuticals announced a corporate rebranding to Eocene with a new ticker symbol (EOCN), which likely triggered investor enthusiasm for the company's strategic repositioning and new platform focus on GI innovation.

The company's rebranding announcement was released on the same day as the 21% gain, making it the most plausible catalyst for the move. A rebrand to a new ticker symbol often signals a strategic inflection point or renewed focus, which can attract fresh investor interest or spark short-covering if the market had previously undervalued the company. The headline emphasizes a "New Dawn Platform for GI Innovation," suggesting management is repositioning away from or expanding beyond prior disease focus areas (liver, cardiometabolic, and oncology). Rebrands can also trigger index rebalancing or attract thematic investors aligned with the new identity. However, the headline does not disclose clinical trial results, regulatory approvals, partnerships, or financial guidance that would independently justify such a sharp move, so enthusiasm may rest primarily on sentiment around the rebrand itself.

TONT.WT

Graf Global Corp.

$0.48+$0.08

+20.7%

NAUT

Nautilus Biotechnology, Inc.Healthcare

$1.12+$0.19

+20.5%

NASDAQ · Mkt cap $114 M

No news headlines were found in the last 48 hours, so the 20% gain likely reflects a delayed market reaction to an earlier announcement, technical rebound, or market speculation in a small-cap biotech stock.

Nautilus Biotechnology is a small-cap biotech firm, and the absence of recent news in the 48-hour window does not rule out catalysts from earlier in the week or market factors specific to the sector. Biotech stocks of this size often experience sharp price swings on technical factors, short covering, or broader sector rotation, independent of same-day news flow. The gain is substantial enough that it could reflect a delayed reaction to a previous earnings report, clinical trial update, partnership announcement, or funding event that occurred more than 48 hours prior but is now being digested by the market. Alternatively, this could be a liquidity-driven move in a lower-volume stock responding to options activity or retail interest. Without identifying headlines, attribution remains speculative.

ATXI

Avenue Therapeutics IncHealthcare

$0.65+$0.11

+20.4%

NASDAQ · Mkt cap $824 K

No news headlines were found in the last 48 hours for ATXI, so the 20% gain likely reflects either a delayed market reaction to an older announcement, technical trading in a low-price stock, or untracked corporate development.

Avenue Therapeutics is a small-cap biopharmaceutical company, and ATXI traded at only $0.65, making it susceptible to both legitimate catalysts and technical momentum moves. Without recent news in the provided headlines, the jump cannot be directly attributed to earnings, FDA decisions, or partnership announcements. However, biotech stocks at this price point often respond sharply to clinical trial results, regulatory submissions, or financing news that may not be immediately indexed in mainstream financial RSS feeds. It is also possible that news broke after the snapshot cutoff, or that the move reflects accumulation by retail traders or short covering. Low-float, low-price biotech stocks are particularly prone to outsized daily swings on modest volume.

SDA

Suncar Technology Group IncConsumer Cyclical

$0.60+$0.10

+20.0%

NASDAQ · Mkt cap $74 M

No news headlines directly address SDA or explain its 20% gain. The jump likely reflects technical trading, retail interest in a micro-cap stock, or undisclosed company-specific developments not captured in the provided news feed.

The news snapshot contains no mentions of Suncar Technology Group Inc (SDA) or any event plausibly connected to it. The headlines instead cover major banks, memory chips, bond markets, and state economies—none relevant to an automotive or technology services company trading at $0.60. For micro-cap stocks trading at such low prices, intraday moves of 20% are not uncommon and can be driven by thin liquidity, short covering, retail momentum trading, or news that circulates on social media or company channels but does not reach mainstream financial news outlets. Without access to SDA-specific news, insider filings, or trading volume data, attributing this move to a particular catalyst would be speculation.

SKYE

Skye Bioscience, Inc.Healthcare

$2.22+$0.37

+20.0%

NASDAQ · Mkt cap $13 M

No news headlines were found in the last 48 hours, so the 20% gain cannot be directly attributed to a reported event. The jump likely reflects either a delayed market reaction to earlier news, a technical or sentiment shift, or an untracked announcement.

With no recent news in the provided feed, the cause of SKYE's 20% single-day gain is not directly evident from headlines. Skye Bioscience is a small-cap biotech firm, and moves of this magnitude in such stocks are often triggered by clinical trial results, regulatory decisions, partnership announcements, or shifts in investor sentiment around pipeline assets. It is also possible the stock experienced a technical or short-covering bounce, particularly if it had been depressed prior to this date. Without access to news beyond the 48-hour window or off-feed announcements, the specific catalyst remains unknown. A reasonable step would be to review company press releases, SEC filings, or social media directly on the snapshot date.

ROCL

Roth Ch Acquisition V Co.Financial Services

$6.48+$1.07

+19.8%

NASDAQ · Mkt cap $27 M

No news emerged in the last 48 hours to explain the 19.78% gain in ROCL, a blank-check company, so the jump likely stems from technical trading, a delayed announcement, or market speculation.

Roth Ch Acquisition V Co. is a SPAC (special purpose acquisition company) with no reported headlines in the past two days despite a significant intraday gain that ranks it among the day's top 26 gainers. Without news of a merger announcement, completed business combination, or other corporate event, the catalyst is unclear. SPACs are historically sensitive to rumor, short covering, and technical momentum, especially when trading near their sponsor redemption thresholds. A 19.78% move on a SPAC can reflect either incoming deal news not yet captured in the RSS feed, options activity, or accumulated buying pressure from retail or algorithmic traders. Without access to real-time trading data or pre-market news wires, the precise trigger cannot be pinpointed.

CULP

Culp Inc

$3.49+$0.66

+19.3%

WYTC

WYTEC INTERNATIONAL INC

$1.19+$0.19

+19.0%

NASDAQ

No news headlines were found in the last 48 hours, so the 19% gain on WYTC remains unexplained by public announcements. The move likely reflects either a delayed news event, technical trading, or market rumors not yet captured in financial news feeds.

The absence of any Yahoo Finance headlines in the 48-hour window before this significant 19% jump makes it impossible to anchor the move to a specific catalyst. For a small-cap stock like WYTEC trading at $1.19, several common drivers could apply: a delayed press release not yet indexed by major news aggregators, a penny-stock or short-squeeze rally driven by retail interest on social platforms, an earnings beat or guidance raise announced after market close on the prior day, or execution of a previously announced business development milestone. Without access to the company's investor relations channels, SEC filings timestamped on the snapshot date itself, or social media sentiment data, attributing causation requires inference rather than evidence. The stock's ranking as the 28th biggest gainer suggests broad market participation in the move, which slightly favors a real news event over pure technical action, but this remains speculative.

ETS

ELITE EXPRESS HOLDING INCIndustrials

$1.30+$0.20

+18.2%

NASDAQ · Mkt cap $54 M

No news headlines were found in the last 48 hours for ETS, so the 18.18% gain likely reflects either technical buying, a delayed market reaction to an earlier announcement, or speculative momentum in a low-priced stock.

Elite Express Holding Inc showed no recent news coverage in the Yahoo Finance RSS feed as of the snapshot date, which means we cannot ground the move in a specific corporate announcement, earnings release, contract win, or guidance change. For micro-cap stocks trading under two dollars, price movements of this magnitude can occur from several sources: delayed market digestion of news released before the 48-hour window, short-covering or technical breakouts above resistance levels, retail interest in penny-stock movers, or broad sector momentum. Without headlines explicitly tied to this stock, we cannot definitively identify the catalyst. The absence of news coverage itself suggests this may be a technical or sentiment-driven move rather than a fundamental event.

TAVIR

Tavia Acquisition Corp. Right

$0.11+$0.02

+17.7%

ZTG

Zenta Group Company LimitedIndustrials

$0.76+$0.12

+17.0%

NASDAQ · Mkt cap $30 M

Zenta Group announced an acquisition of ZentoAI Intelligent Technology Company Limited to expand its AI and big data business in East Asia, likely driving the 17% gain as investors rewarded the strategic expansion move.

On September 9, 2026, Zenta Group announced an agreement to acquire ZentoAI Intelligent Technology Company Limited. The stated rationale centers on expanding the company's AI and big data business segment and strengthening its regional presence in East Asia. This is a concrete M&A announcement released the same day as the price action. The market typically responds positively to strategic acquisitions in high-growth sectors like AI, particularly when they offer geographic diversification and business line expansion. The gain of 17% ranks ZTG as the 31st biggest gainer for the day, suggesting the market viewed this as accretive news. However, the headline provided is incomplete—it does not detail acquisition terms, financing method, integration risks, or expected financial impact, so the precise mechanism by which the market sized this benefit remains partially obscured.

RIBB

Ribbon Acquisition Corp Class A Ordinary Shares

$14.85+$1.85

+17.0%

BNCWW

CEA Industries Inc. WarrantIndustrials

$0.01+$0.00

+15.6%

NASDAQ

No news headlines were available in the last 48 hours to explain the 15.56% gain in this warrant. The move likely reflects technical trading activity, renewed interest in the underlying CEA Industries stock, or a delayed market reaction to a prior announcement.

Warrant prices are highly sensitive to moves in their underlying stock and can amplify small percentage gains in the common equity into larger warrant moves due to leverage and time-decay dynamics. With no recent news found on Yahoo Finance in the last 48 hours, the catalyst is not immediately identifiable from public headlines. However, warrants in this price range, especially those trading at or near $0.01, frequently experience sharp intraday swings driven by technical factors, low volume spikes, or retail interest. It is also possible that news or an announcement occurred outside the 48-hour window or on a venue not captured by the RSS feed, and the market is reacting with a delay. Without specific information about the underlying company's recent activity or warrant structure, pinpointing the exact cause is not possible from the evidence at hand.

BRNX

Brenx Ltd.

$2.65+$0.35

+15.2%

MOBQ

Mobiquity Technologies, Inc.Communication Services

$0.69+$0.09

+15.2%

NASDAQ · Mkt cap $19 M

No news headlines were found in the last 48 hours, so the 15% gain on MOBQ likely reflects a technical bounce, short covering, or a delayed market reaction to an untracked announcement or rumor.

MOBQ shows a significant single-day gain of 15.19% ranking it 35th among daily gainers, yet zero news was captured in the Yahoo Finance RSS feed over the prior 48 hours. This disconnect creates genuine uncertainty about the catalyst. For a micro-cap technology stock like Mobiquity, such moves are often driven by technical factors including short-covering rallies, algorithmic trading, or retail investor momentum rather than fundamental news. Alternatively, a company announcement, acquisition rumor, or regulatory development may have occurred but not yet been indexed by the RSS feed used here. Without corroborating headlines, we cannot determine whether this was a planned disclosure, market-driven technical event, or information asymmetry between news sources.

AGRZ

Agroz Inc.Consumer Defensive

$0.26+$0.03

+14.9%

NASDAQ · Mkt cap $6.9 M

Agroz announced a multi-year strategic supply agreement with Harvest Hive providing access to produce from 500+ acres in Malaysia, a material expansion of production capacity that likely triggered the 14.86% gain.

On 2026-09-09, Agroz disclosed execution of a strategic supply agreement with Harvest Hive granting access to aggregated produce from over 500 acres in Cameron Highlands, Malaysia. This represents tangible capacity expansion for a controlled environment agriculture and precision ag technology company. For micro-cap stocks like AGRZ trading at $0.26, announcements of new supply partnerships and material acreage additions can drive outsized gains if investors view them as revenue-accretive or as validation of the company's business model. The timing of two nearly identical announcements within hours suggests an official press release distribution, indicating this is a formal corporate milestone rather than a rumor or technical event. The magnitude of the move aligns with typical penny-stock reactions to supply or partnership news.

GAME

Engine Media Holdings, Inc.

$3.51+$0.45

+14.7%

ASO

Academy Sports & Outdoors IncConsumer Cyclical

$51.20+$6.49

+14.5%

NASDAQ · Mkt cap $2.7 B

Academy Sports reported Q2 earnings that beat expectations and raised its full-year profit guidance on cost discipline and e-commerce growth, driving a 14.52% rally despite flat comparable sales.

The stock climbed sharply on September 9 following the release of second-quarter fiscal 2026 results announced that morning. The company delivered earnings surprises of 10%, with diluted GAAP EPS of $2.17 up 17.3% year-over-year and adjusted EPS of $2.31. Despite comparable sales declining 0.4% and total sales rising just 3%, investors focused on margin expansion (440 basis points gross margin improvement), strong e-commerce growth of 12.8%, and cost discipline achievements. Most notably, management raised its full-year adjusted profit forecast despite acknowledging pressure on consumer spending. The premarket reaction was notably strong at 11%, and the stock continued climbing through the day, suggesting sustained positive sentiment around profitability momentum and forward guidance even as topline growth remained muted.

FTK

Flotek Industries IncEnergy

$27.89+$3.53

+14.5%

NYSE · Mkt cap $860 M

Flotek raised its full-year 2026 revenue guidance to $360-$370 million on stronger-than-expected international chemistry sales, directly explaining the 14.49% gain on September 9.

Flotek Industries announced a second guidance raise for 2026, citing continued strength in international chemistry sales driving higher revenue and Adjusted EBITDA than previously forecast. The company upgraded its full-year outlook, signaling confidence in sustained demand and execution. Guidance raises are typically well-received by equity markets because they demonstrate management's ability to forecast accurately, validate business momentum, and often signal confidence in near-term results. The timing of two announcements on the same trading day—one at 10:30 UTC and one at 12:47 UTC—suggests the formal release came later in the morning, allowing time for the market to digest and react. International sales strength is particularly noteworthy for a chemicals/specialty materials company, as it indicates geographic diversification and global demand resilience.

PMN

ProMIS Neurosciences, Inc.Healthcare

$14.18+$1.75

+14.1%

NASDAQ · Mkt cap $131 M

No news headlines were found in the last 48 hours, so the 14.11% gain on PMN likely reflects either a delayed market reaction to an earlier announcement, technical trading activity, or an untracked catalyst such as a clinical update or partnership news.

The absence of any headlines in the Yahoo Finance RSS feed over the last two days makes it impossible to pinpoint a specific catalyst for PMN's strong 14.11% jump to $14.18. ProMIS Neurosciences is a clinical-stage biotech company focused on neurodegenerative disease therapies, and stocks in this category typically respond sharply to clinical trial results, regulatory milestones (IND approvals, meeting outcomes with the FDA), partnership announcements, or financing news. The move could reflect a delayed market digestion of news released just outside the 48-hour window, a favorable development announced through a channel not captured by the RSS feed, or technical momentum if the stock had been consolidating. Without access to company press releases, regulatory filings, or broader market context for the trading day, the specific driver remains unclear.

GIWWR

GigCapital8 Corp. Rights

$0.25+$0.03

+13.6%

CALC

CALCIMEDICA INCHealthcare

$2.30+$0.28

+13.6%

NASDAQ · Mkt cap $19 M

CalciMedica announced participation in the H.C. Wainwright 28th Annual Global Investment Conference on September 8, which likely drove investor interest and the 13.61% gain on September 9.

The only headline provided is a conference participation announcement from September 8. CalciMedica is a clinical-stage biopharmaceutical company developing CRAC channel modulators. Conference participation announcements are typically minor catalysts, but for small-cap biotech stocks they can attract investor attention, particularly if the company plans to present clinical data, financial updates, or strategic insights at the event. The timing aligns well with the stock's jump the next trading day. However, the headline snippet is incomplete and does not detail what CalciMedica will actually present or announce at the conference, so we cannot rule out other concurrent developments. The move is modest in absolute terms for a microcap biotech, making it consistent with increased attention from a scheduled investor presentation rather than a transformative event.

CDLX

Cardlytics IncCommunication Services

$4.28+$0.48

+12.6%

NASDAQ · Mkt cap $24 M

No news headlines were found in the last 48 hours, so the 12.63% jump in CDLX likely reflects either delayed market reaction to an earlier announcement, technical trading, or an untracked catalyst such as an insider transaction or analyst upgrade.

Cardlytics is a fintech company focused on digital marketing and customer engagement through banking relationships. Without recent news, we cannot point to a specific corporate event like earnings, product launches, partnerships, or guidance changes. The stock's roughly 13% single-day gain ranks it among the top gainers but lacks headline support. This could indicate several possibilities: first, a delayed market reaction to news that was published just outside the 48-hour window; second, short covering or technical momentum in a lower-volume name; third, an untracked announcement such as an analyst initiation, institutional buying, or insider activity. Fintech and marketing-technology stocks can be volatile, and Cardlytics' relatively modest market cap may amplify intraday moves on modest volume. Without corroborating headlines, we are estimating the likely category rather than identifying a confirmed cause.

MTNE.WT

CH4 Natural Solutions Corp WT

$0.36+$0.04

+12.5%

ALPXR

Alpex Acquisition Corporation Rights

$0.18+$0.02

+12.5%

MLAC

Malacca Straits Acquisition Co Ltd

$0.96+$0.10

+12.1%

NASDAQ · Mkt cap $12 M

No news headlines were available in the last 48 hours to explain the 12.06% gain. The move likely reflects a specific event or rumor not yet captured in major news feeds, common for low-priced SPAC or microcap securities.

MLAC is a blank-check acquisition company, which means it is searching for a business to merge with or acquire. These securities often experience sharp price movements on relatively low volume when rumors of potential merger targets circulate, even before official announcements reach mainstream financial news outlets. The stock trades at $0.96, suggesting limited liquidity and analyst coverage, which amplifies volatility. Without access to social media, press releases, or specialized SPAC tracking services, the specific catalyst cannot be identified here. The move could reflect an internal rumor, a leaked announcement, or simply technical trading in a thinly traded security. Historical patterns for SPACs show that mergers, target confirmations, and deal timeline updates are the primary drivers of price swings, but those details are not present in the data provided.

RAY

Raytech Holding Limited Ordinary SharesConsumer Defensive

$2.80+$0.32

+12.0%

NASDAQ · Mkt cap $16 M

Raytech announced a corporate rebrand to Atlas Trinity Tech with a ticker change to ATTT effective September 10, 2026, likely triggering investor positioning ahead of the symbol migration and renewed interest in the renamed entity.

The company announced an official name change from Raytech Holding Limited to Atlas Trinity Tech Limited, with the ordinary shares set to begin trading under the new ticker symbol ATTT at market open on September 10, 2026. This type of corporate rebrand announcement often generates trading activity as investors reposition ahead of the symbol switch, existing shareholders decide whether to hold through the transition, and some traders speculate on renewed visibility or sentiment tied to the new brand identity. The timing of the announcement on September 9 with an effective date of September 10 creates urgency. However, the headline excerpt does not disclose the strategic rationale, business drivers, or operational catalysts behind the rebrand, so the move may reflect pure mechanical trading around the event rather than fundamental business improvement.

INDP

Indaptus Therapeutics, Inc.Healthcare

$2.06+$0.22

+12.0%

NASDAQ · Mkt cap $125 M

No news headlines were published in the last 48 hours for INDP, so the 11.96% gain on September 9, 2026 lacks confirmed catalyst information from standard news sources. The move could reflect technical trading, an untracked announcement, or broader market sentiment toward small-cap biotech.

Indaptus Therapeutics is a small-cap clinical-stage biopharmaceutical company, and the absence of any Yahoo Finance RSS headlines in the past 48 hours means we cannot attribute this jump to earnings, FDA actions, trial results, or partnership announcements. For companies of this size and stage, price moves of this magnitude are often driven by technical factors such as short covering or algorithmic rebalancing, clinical trial updates released directly by the company rather than through major news wires, discussions on retail investment platforms, or broader sector sentiment shifts in biotech. Without headline confirmation, any explanation remains speculative. The move ranks highly (48 biggest gainer), suggesting it attracted enough volume to be notable, but the absence of corresponding news coverage is striking.

BAND

Bandwidth IncTechnology

$48.83+$5.17

+11.8%

NASDAQ · Mkt cap $1.5 B

No news headlines were found in the last 48 hours to explain Bandwidth Inc's 11.84% gain on September 9, 2026, so the catalyst remains unclear from public sources.

Bandwidth Inc jumped nearly 12% to $48.83 with no identifiable news catalyst in the recent headline feed. This absence makes causation speculative. For a telecom/communications software company like BAND, typical drivers of single-day rallies include earnings surprises, contract wins, analyst upgrades, sector rotation momentum, short-covering activity, or market-wide risk-on sentiment. Without headlines, we cannot distinguish between these possibilities. It's also possible the move reflects delayed market reaction to news that hasn't yet propagated through the RSS feed, or reflects intraday technical momentum or options-related flows. The stock's rank as the 49th biggest gainer suggests broad-market participation rather than isolated BAND-specific news, which could point toward sector tailwinds rather than company-specific catalysts.

XHLD

TEN Holdings, Inc. Common StockCommunication Services

$10.51+$1.11

+11.8%

NASDAQ · Mkt cap $92 M

TEN Holdings rose 11.81% on news of a presentation at the H.C. Wainwright investment conference, though the headline does not specify material new information that would typically drive such a move.

The only recent headline provided is an announcement that TEN Holdings will present at the H.C. Wainwright 28th Annual Global Investment Conference on September 8, 2026. This is a routine investor relations event notification rather than disclosure of earnings results, product launches, partnerships, or strategic developments. Conference presentations alone rarely drive double-digit stock moves unless they are accompanied by major news or market anticipation of specific announcements to be made during the event. The 11.81% gain could reflect investor optimism ahead of the presentation, short covering, technical momentum in a small-cap name, or positive sentiment unrelated to the headline provided. Without access to the full content of any remarks or specific items the company plans to discuss at the conference, we cannot definitively link the price move to the headline.

Biggest Losers

Wed, Sep 9, 2026 50

AACI

Armada Acquisition Corp. IFinancial Services

$2.30−$7.74

-77.1%

NASDAQ · Mkt cap $341 M

No news headlines were published in the last 48 hours, so the cause of the 77% plunge is not directly identifiable from available reporting. A SPAC or shell company collapse, merger termination, delisting warning, or sudden insider action are plausible but unconfirmed possibilities.

Armada Acquisition Corp. I is a blank-check company (SPAC), a security class prone to sharp moves on deal announcements, terminations, redemptions, or regulatory actions. The absence of any news in the last 48 hours despite the stock ranking as the number-one biggest loser of the day suggests either a very recent development not yet picked up by Yahoo Finance's RSS feed, a shareholder vote outcome, a regulatory filing (such as a delisting notice or going-concern warning), or an unannounced deal breakup. SPACs also face redemption pressure and deadline expirations that can trigger cascading sell-offs. Without headlines or filings explicitly documented here, the specific catalyst remains unknown, though the magnitude of the loss points to a fundamental event rather than technical selling or rotation.

CRMT

America's Car-Mart Inc-TXConsumer Cyclical

$1.48−$1.06

-41.6%

GRNQ

Greenpro Capital CorpIndustrials

$12.53−$6.22

-33.2%

NASDAQ · Mkt cap $24 M

No news headlines were found in the last 48 hours to explain GRNQ's 33% single-day drop, suggesting the move was driven by company-specific developments, market sentiment, or technical factors not captured in available public announcements.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for GRNQ's sharp decline. Greenpro Capital Corp is a micro-cap financial services and blockchain-focused company with historically limited analyst coverage and press releases. For stocks in this category, large one-day moves often stem from several possible sources: delayed or overnight announcements not yet reflected in RSS feeds, insider selling or filing releases, margin calls or forced liquidations tied to broader market stress, short-seller reports or social media pressure, or technical breakdown through support levels that triggers algorithmic selling. Without documented news, the exact trigger remains speculative, though the 33% magnitude suggests a material negative event rather than routine noise.

SZZL

Sizzle Acquisition Corp.Financial Services

$7.07−$3.38

-32.3%

NASDAQ · Mkt cap $327 M

No news headlines were found in the last 48 hours, so the 32% drop cannot be attributed to a specific announced event; the decline likely reflects either a delayed reaction to prior news, a technical or market-wide pullback, or an unannounced development.

The absence of any news in the Yahoo Finance RSS feed over the last 48 hours makes it impossible to pinpoint a direct catalyst for the sharp 32% decline in SZZL. As a SPAC (special purpose acquisition company), this stock is typically sensitive to merger announcements, deal terminations, shareholder votes, or warrant/redemption activities. The magnitude of the drop suggests something material occurred, but without headline evidence it could be a delayed market reaction to earlier news, deteriorating market conditions affecting SPACs broadly, redemption pressures, insider activity, or an unannounced development that has not yet hit the major news wires. Technical or sentiment-driven selling is also possible in a thinly traded acquisition vehicle.

LEXX

Lexaria Bioscience Corp.Healthcare

$6.42−$2.97

-31.6%

NASDAQ · Mkt cap $19 M

Lexaria announced the closing of a $5.9 million warrant exercise on September 9, which likely triggered shareholder dilution concerns and a major selloff that made LEXX the fifth-biggest loser of the day, falling 31.63%.

On September 8-9, Lexaria announced the entry into and subsequent closing of a warrant exercise agreement that generated approximately $5.9 million in gross proceeds. While the company also released positive news on September 8 regarding DehydraTECH 3.0 absorption data from an animal study, the warrant closing on September 9 appears to have dominated market sentiment. Warrant exercises are commonly perceived negatively by existing shareholders because they dilute equity ownership and are often associated with capital-raising in companies facing cash constraints. The magnitude of the drop—31.63%—suggests the market interpreted this dilutive event as outweighing the technical achievement announced the previous day. Without explicit analyst commentary or guidance changes in the headlines, the warrant exercise remains the most concrete catalyst aligned with the timing and magnitude of the decline.

TTAN

ServiceTitan, Inc. Class A Common Stock

$57.12−$24.23

-29.8%

NUR

Nuran Wireless Inc.

$1.54−$0.54

-26.4%

MWYN

Marwynn Holdings, Inc. Common stockConsumer Cyclical

$0.90−$0.32

-26.2%

NASDAQ · Mkt cap $21 M

MWYN fell 26.21% on September 9 with no news headlines in the last 48 hours, making the specific catalyst unclear; the drop likely reflects either a delayed announcement not yet indexed by RSS feeds, broad market pressure on micro-cap stocks, or a company-specific event not captured in available …

The absence of recent news headlines within the 48-hour window preceding this sharp 26% decline makes it difficult to identify a definitive catalyst. MWYN trades at $0.90 as a micro-cap security on NASDAQ, which means it is more susceptible to lower liquidity, wider bid-ask spreads, and outsized price swings on relatively modest volume changes. Possible explanations include a significant earnings miss or negative guidance that has not yet propagated to major news feeds, an insider or institutional sell-off, a delisting warning from the exchange, a failed fundraising attempt, or a clinical or regulatory setback if the company operates in biotech, healthcare, or similarly regulated sectors. Micro-cap stocks also face elevated risks from technical breakdowns, forced liquidations, or negative social media commentary that can move prices faster than traditional news dissemination.

SSM

Sono Group N.V.Consumer Cyclical

$2.35−$0.76

-24.3%

NASDAQ · Mkt cap $3.8 M

No news headlines were found in the last 48 hours to explain SSM's 24.28% single-day plunge, making the precise catalyst unclear. The drop may reflect market sentiment shifts, technical selling, or delayed reactions to older developments in the solar vehicle or EV sector.

Sono Group is a solar-integrated vehicle manufacturer, a speculative growth name in the EV space with inherent volatility. The absence of news in the immediate 48-hour window does not rule out broader market dynamics, sector rotation, or responses to older earnings or guidance. Solar and EV stocks have experienced cyclical pressure based on macroeconomic conditions, interest rates, and competitive pressures. Without a specific headline trigger, the decline could stem from technical factors such as stop-loss cascades, fund rebalancing, or a delayed market reaction to company developments or sector headwinds announced earlier. Sono's low share price and small market cap also make it prone to higher intra-day volatility unmoored from fundamental catalysts.

TNON

Tenon Medical, Inc.Healthcare

$2.44−$0.80

-24.0%

NASDAQ · Mkt cap $2.4 M

Tenon Medical announced early repayment of convertible notes on September 9, which the market interpreted negatively despite management framing it as balance-sheet strengthening, likely due to cash outlay concerns or dilution questions outweighing the stated benefits.

The only news headline provided announces that Tenon Medical has chosen to repay convertible notes early. Management positioned this as a proactive step to strengthen the balance sheet and maintain flexibility for business execution. However, the stock fell nearly 24 percent on the same day the announcement was made. This disconnect suggests the market may have focused on the immediate cash impact of repayment, questions about why the company needed to shore up liquidity if business momentum is strong, or concerns that the move signals less financial flexibility rather than more. It is also possible the market was disappointed by the lack of any positive operational or financial update accompanying the announcement, or worried about the dilutive or balance-sheet implications of how the repayment will be funded. Without additional detail on the notes, redemption price, or forward guidance, the exact reason for the selloff remains ambiguous.

BBOT

BridgeBio Oncology Therapeutics, Inc.

$6.75−$2.10

-23.7%

VWAV

VisionWave Holdings, Inc.Industrials

$0.46−$0.14

-23.5%

NASDAQ · Mkt cap $36 M

No news headlines were found in the last 48 hours, so the 23.46% drop likely stems from a delayed announcement, technical selling, or market-specific pressure on this micro-cap stock.

VisionWave Holdings experienced a significant single-day decline of nearly 24% with no corresponding headlines in the last two days on Yahoo Finance RSS. This absence of news is notable and suggests several possible explanations. The most common catalysts for micro-cap stocks like VWAV include delayed earnings announcements or guidance revisions from prior days, insider selling, short-seller reports or negative social media commentary, technical breakdown of support levels, or broad sector weakness in whatever industry VisionWave operates in. Without access to the company's recent filings, earnings calendar, or sector-specific news, we cannot pinpoint the specific trigger. The lack of covered news does not mean no news exists; company-specific announcements may simply not have been picked up by the RSS feed monitored here.

RFAI

RF Acquisition Corp II Ordinary SharesFinancial Services

$32.00−$9.61

-23.1%

NASDAQ · Mkt cap $93 M

No news headlines were available in the last 48 hours, so the 23% drop on RFAI cannot be attributed to a specific disclosed event; the decline may reflect SPAC-related risks, merger concerns, or broader market sentiment toward blank-check companies.

RFAI is an acquisition corp (SPAC), a structure highly sensitive to deal completion timelines, regulatory approval risks, and investor sentiment toward blank-check vehicles. The absence of any recent news despite a sharp single-day loss suggests either a delayed market reaction to an earlier announcement, unconfirmed rumors or speculation circulating among traders, or a technical selloff in response to broader sector headwinds affecting SPACs. SPAC shares often trade on confidence in management and deal prospects rather than fundamentals; loss of confidence or uncertainty about merger terms, timing, or closing conditions can trigger rapid repricing. Without a specific catalyst visible in public headlines, the decline is most likely attributable to one of these structural factors common to blank-check entities rather than company-specific news.

TBBK

Bancorp Inc-The

$50.01−$14.49

-22.5%

COO

Cooper Cos Inc-TheHealthcare

$63.60−$15.25

-22.3%

NASDAQ · Mkt cap $14 B

Cooper Companies plunged 22% after reporting Q3 earnings that beat on EPS but missed revenue expectations and issued weak Q4 guidance, despite concluding a strategic review to retain CooperSurgical.

The stock fell sharply on September 9 after the company reported fiscal Q3 adjusted earnings of $1.15 per diluted share, which beat estimates by 3.6%, but revenue came in 2.97% below expectations at $1.07 billion and flat year-over-year. The primary catalyst for the 22% decline appears to be forward-looking weakness: Q4 guidance disappointed the market, signaling slowing momentum ahead. Additionally, the company's conclusion of its strategic review to retain CooperSurgical (rather than divest it) may have disappointed investors who expected a breakup or asset sale to unlock value. The disconnect between the earnings beat and revenue miss, combined with disappointing guidance, suggests market concerns about underlying business momentum despite cost control and operational efficiency gains that drove the EPS beat.

FJET

STARFIGHTERS SPACE INCIndustrials

$2.05−$0.59

-22.2%

NYSE · Mkt cap $218 M

Starfighters announced a collaboration with Vaya on air-launch projects on September 9, but the stock fell 22% the same day, suggesting the market viewed the partnership as insufficient or disappointing relative to prior expectations or investor sentiment on the hypersonic sector's near-term pros…

The two headlines released on September 9 present a mixed narrative. Starfighters announced a collaboration with Vaya Space on air-launch and captive carry projects, which is a concrete partnership announcement. However, the accompanying industry commentary highlights a critical constraint: flight test time has become the bottleneck in hypersonic technology development. While the market is projected to reach $15.73 billion by 2030, the practical limitation of testing infrastructure suggests commercialization may face delays. The sharp 22% decline on the day of the partnership announcement—rather than an enthusiastic rally—implies the market either already priced in expectations of this collaboration, viewed it as incremental rather than transformative, or interpreted the industry commentary about testing bottlenecks as a headwind to near-term revenue growth and margin expansion for companies like Starfighters.

BRZE

Braze, Inc. Class A Common StockTechnology

$23.73−$6.62

-21.8%

NASDAQ · Mkt cap $3.7 B

Braze fell 21.8% after reporting Q2 earnings that beat revenue expectations and raised full-year guidance, but issued third-quarter earnings guidance below analyst expectations, disappointing investors despite strong AI adoption metrics.

Braze reported fiscal Q2 2026 revenue of $227.2 million, up 26.2% year-over-year, which exceeded market expectations, and raised its full-year outlook. The company also highlighted accelerating adoption of BrazeAI tools and strong contract expansion activity. However, the third-quarter adjusted earnings guidance came in below analyst expectations, triggering the sharp selloff. This pattern—a beat on revenue and raised full-year guidance combined with disappointing near-term earnings guidance—created a mixed signal that the market resolved negatively. Notably, Klaviyo, a sector peer, advanced 3% on the same day, suggesting the decline was company-specific rather than sector-wide. Multiple Wall Street analysts including Raymond James, UBS, Canaccord, Stifel, and Stephens characterized the post-earnings weakness as a buying opportunity, raising or reaffirming price targets. The underlying tension appears to be between growth fundamentals and near-term profitability expectations in a software sector heavily focused on AI adoption narratives.

LHSW

Lianhe Sowell International Group Ltd Ordinary SharesTechnology

$1.03−$0.29

-21.6%

NASDAQ · Mkt cap $9.6 M

No news headlines were available in the last 48 hours to explain LHSW's sharp 21.64% decline on September 9, 2026. The drop likely stems from technical selling, delayed news, or company-specific developments not yet reflected in public headlines.

The absence of any Yahoo Finance headlines in the last 48 hours makes it impossible to identify a specific catalyst for this substantial single-day decline. LHSW is a thinly-traded over-the-counter or lower-volume exchange stock, which typically experiences larger percentage swings on modest volume and can be sensitive to delayed news dissemination. Possible explanations in this category include company reporting or guidance changes that have not yet surfaced in headline feeds, technical breakdown or forced liquidations in a low-liquidity name, unconfirmed rumors or insider activity, or negative developments announced through direct channels rather than press releases. Without access to company filings, SEC announcements, or intraday trading data, no conclusion can be drawn about the true cause.

OCGN

Ocugen IncHealthcare

$1.07−$0.27

-19.9%

NASDAQ · Mkt cap $456 M

No news headlines were found in the last 48 hours to explain Ocugen's 19.91% single-day drop, suggesting the decline may be driven by technical selling, sector rotation, or undisclosed negative developments.

The absence of any news in the last 48 hours makes it difficult to pinpoint a specific catalyst for Ocugen's nearly 20% decline. Ocugen is a clinical-stage biopharmaceutical company, and stocks in this category are typically sensitive to clinical trial results, FDA decisions, funding announcements, or pipeline updates. Given the sharp move and lack of headline coverage, the decline could reflect technical selling following a prior rally, broad market or biotech sector weakness, or a negative development (clinical hold, trial failure, financing delay) that has not yet been captured in the Yahoo Finance RSS feed used here. Retail-driven biotech stocks can also experience intraday volatility unmoored from news, though this magnitude warrants caution. Without recent headlines, any explanation remains speculative.

AMCI

AMCI Acquisition CorpTechnology

$3.20−$0.78

-19.6%

NASDAQ · Mkt cap $115 M

No news headlines were found in the last 48 hours, so the 19.6% drop cannot be attributed to a specific disclosed event. AMCI, a SPAC, may have experienced a sharp decline due to redemption pressure, failed merger negotiations, or broader SPAC sentiment deterioration.

The absence of recent news makes direct attribution impossible. However, AMCI is a special purpose acquisition company, which is a structural category prone to sharp declines when redemption windows open, merger timelines slip, or announced business combinations face headwinds. SPAC equities also exhibit heightened sensitivity to market-wide shifts in sentiment toward blank-check vehicles. The 19.6% single-day drop is consistent with either a redemption event, a missed deadline announcement, or negative guidance on deal completion. Without headlines, we cannot determine which scenario applies, and the move could alternatively reflect technical selling, short covering reversal, or an unannounced development that has not yet propagated to public wires.

AQMS

Aqua Metals IncIndustrials

$2.40−$0.56

-18.9%

NASDAQ · Mkt cap $10 M

No news headlines were found in the last 48 hours to explain the 18.92% drop, so the cause remains unclear from available reporting.

AQMS fell sharply on September 9th with no recent news coverage to point to a specific catalyst. Aqua Metals is a lead-acid battery recycling company, a small-cap stock that can be subject to larger percentage swings on lower trading volume. Without headlines, potential explanations could include delayed market reaction to prior announcements, sector-wide weakness in recycling or battery stocks, technical selling or stop-loss cascade, insider transactions, or undisclosed operational developments. The 21st-largest daily loser ranking suggests this was part of broader market movement rather than a stock-specific surprise, though that too is inference without supporting data. Investors should check the company's recent filings and contact relations for context the RSS feed may have missed.

NAVN

Navan, Inc.Technology

$25.92−$5.00

-18.8%

NASDAQ · Mkt cap $7.0 B

Navan fell 18.77% despite announcing strong Q2 results, a strategic partnership, and the BoomPop acquisition, suggesting the market's earnings expectations or forward guidance disappointed relative to the stock price run-up.

On September 9, 2026, Navan announced Q2 fiscal 2027 results described as "strong," along with two positive catalysts: a strategic technology partnership with Engine and the acquisition of AI-powered events platform BoomPop. However, the stock plummeted 18.77% the same day. The available headlines do not provide actual financial figures, earnings beats or misses, or forward guidance metrics that would explain such a sharp decline. The most likely explanation is that while the headlines use positive language, the actual earnings metrics—revenue growth rate, margins, customer additions, or fiscal 2027 guidance—either missed analyst consensus or disappointed relative to pre-announcement expectations. This type of "sell-the-news" pattern is common when acquisitions are announced alongside earnings that do not match the bullish tone of press releases.

FGL

Founder Group Limited Ordinary SharesIndustrials

$6.83−$1.50

-18.2%

NASDAQ · Mkt cap $475 K

FGL dropped 18.25% with no news headlines in the last 48 hours, making the specific cause unclear; the move may reflect delayed reaction to earlier information, technical selling, or market-specific factors.

No headlines appeared in the last 48 hours to explain FGL's steep 18% decline, which places it among the day's worst performers. This absence of contemporaneous news coverage makes direct attribution impossible. The drop could reflect a delayed market reaction to older announcements not captured in the recent RSS feed, broad sector weakness affecting the stock, technical breakdown through a key support level, options expiration mechanics, or shifts in sentiment among retail or institutional holders. Without access to the company's sector, float structure, recent earnings history, or institutional ownership pattern, it is not possible to narrow the explanation further. The stock's NASDAQ listing and sharp single-day loss suggest material concern among traders, but the catalyst remains unknown from the available evidence.

TYRA

Tyra Biosciences, Inc.Healthcare

$22.02−$4.75

-17.7%

BCSS.WT

Bain Capital GSS Investment Corp. WT

$0.65−$0.14

-17.7%

NNOX

Nano-X Imaging LtdHealthcare

$0.77−$0.16

-17.4%

NASDAQ · Mkt cap $69 M

Nano-X reported strong 37% revenue growth in Q2 2026, but a $40.7 million non-cash impairment charge and widening GAAP losses likely triggered the 17% sell-off, signaling investor concern about profitability despite top-line strength.

The earnings headlines establish that Nano-X delivered robust revenue growth of 37% to $4.2 million, driven by teleradiology, health IT, and AI services. However, the company also took a substantial $40.7 million impairment charge, which widened its GAAP net loss to $55 million. While impairments are non-cash charges and thus do not directly affect cash flow, they often signal asset quality concerns or strategic reassessment that can spook investors, particularly in high-growth but unprofitable biotech and medical device firms. The confluence of strong growth alongside massive losses and an impairment suggests the market may be repricing risk: investors may be questioning whether revenue growth can ever overcome the deep burn rate, or whether the impairment reflects weakness in the core business model or asset base that top-line metrics are masking.

NWAX.WT

New America Acquisition I Corp. WT

$0.38−$0.08

-17.0%

SST

SPDR Blmbg Barclays ST Treasury ETFIndustrials

$4.41−$0.90

-17.0%

NYSE · Mkt cap $22 M

SST is a short-term Treasury ETF, not System1 Inc.; the -16.98% drop likely reflects a sharp rise in short-term Treasury yields rather than any corporate news about MapQuest users.

There is a critical ticker mismatch here. SST on NYSE is the SPDR Bloomberg Barclays Short-Term Treasury ETF, a fixed-income instrument that moves inversely to short-term Treasury bond prices. The only headline provided announces System1 Inc.'s MapQuest user growth, which is unrelated to Treasury markets. SST's large one-day loss almost certainly reflects a significant upward movement in short-term Treasury yields (likely driven by Fed policy signals, inflation data, or broader rate-market dynamics) rather than any corporate event. The MapQuest headline is noise for this security. Short-term Treasury ETFs experience daily volatility tied to yield curve movements, not tech company user metrics.

FLZH

Flash Sports & Media Holdings, Inc.Communication Services

$0.08−$0.02

-16.9%

NASDAQ · Mkt cap $60 M

No news headlines were published in the last 48 hours, so the 16.94% drop cannot be attributed to any reported event. The decline likely reflects either technical selling pressure, a delayed market reaction to older news, or sector-wide headwinds affecting micro-cap media stocks.

The absence of any recent news coverage within 48 hours of this sharp single-day decline makes direct causation impossible to establish. Flash Sports & Media is a micro-cap stock trading at $0.08, which typically exhibits high volatility and lower liquidity. For stocks in this category, price movements are often driven by factors other than headline news, including technical selling following prior rallies, options expiration effects, or broader sentiment shifts in penny-stock or penny-media sectors. It is also possible that relevant news was published on alternative sources not indexed by Yahoo Finance RSS, or that the decline reflects a delayed market reaction to announcements from one to several days prior. Without access to broader market context for the stock or trading volume data, determining the specific trigger remains speculative.

Ww International Inc

$14.94−$3.03

-16.8%

CRBP

Corbus Pharmaceuticals Holdings IncHealthcare

$8.85−$1.75

-16.5%

NASDAQ · Mkt cap $195 M

No news headlines were found in the last 48 hours to explain CRBP's 16.47% decline, so the driver remains unclear; biotech stocks of this size often sell off on clinical trial setbacks, regulatory delays, or sector rotation.

The absence of any news in the last 48 hours makes it impossible to pinpoint a specific catalyst for CRBP's sharp 16.47% drop to $8.85. Corbus Pharmaceuticals is a clinical-stage biotech company, meaning its stock is typically driven by binary events: trial results, FDA decisions, financing announcements, or partnership news. The lack of reported headlines suggests either the market reaction preceded public disclosure, a private rumor circulated, or the move was triggered by sector-wide biotech weakness. A reasonable inference is that an anticipated clinical readout may have missed, a funding round may have diluted shareholders, or broader biopharma sentiment shifted negative, but without evidence this remains speculation. The rank as the 31st biggest loser indicates significant selling pressure across the market today.

XPOF

Xponential Fitness, Inc.Consumer Cyclical

$4.03−$0.78

-16.1%

NYSE · Mkt cap $269 M

A CFO appointment announcement was released after market close on September 8, but this executive personnel change alone does not typically trigger a 16% single-day drop, suggesting either negative context in the full announcement, a separate negative catalyst, or pre-existing market sentiment th…

The only headline provided is the appointment of Jennifer Ryu as Chief Financial Officer, announced on September 8 after hours. While CFO transitions can signal internal management shifts, a routine executive appointment rarely causes a sharp one-day decline of this magnitude without additional negative context. The headline excerpt provided is incomplete and does not convey any detail suggesting financial distress, governance concerns, or departure of a well-regarded leader. The drop could reflect: (1) deteriorating same-store sales or unit growth trends in the fitness franchise sector, (2) a broader market rotation away from fitness or consumer discretionary stocks, or (3) undisclosed negative operational or financial news released alongside or separately from the CFO announcement. Without access to the full text of the announcement or concurrent earnings/guidance updates, the precise trigger remains unclear.

OLB

The OLB Group, Inc.

$0.33−$0.06

-16.1%

LASE

Laser Photonics CorpIndustrials

$0.80−$0.15

-15.8%

NASDAQ · Mkt cap $67 M

LASE fell 15.76% with no news reported in the last 48 hours, so the driver remains unclear; the drop likely stems from market sentiment, technical selling, or unreported developments.

No headlines from Yahoo Finance RSS in the last 48 hours are associated with this decline, which limits our ability to pinpoint a specific catalyst. Laser Photonics is a small-cap industrial equipment manufacturer, and stocks in this sector can experience sharp intraday moves on limited volume due to thin liquidity. Possible explanations include negative sentiment in the broader industrial sector, a delayed earnings miss or guidance cut that markets are repricing, short-covering or algorithmic selling, or a private development (customer loss, financing news, or insider activity) not yet reflected in headline aggregators. Without corroborating news or fundamental announcement, we cannot establish causation.

UZX

Linkage Global IncConsumer Cyclical

$0.10−$0.02

-15.7%

NASDAQ · Mkt cap $7.8 M

No news headlines were found in the last 48 hours, so the 15.73% decline in UZX appears to be driven by factors other than announced corporate events, though micro-cap stocks often experience sharp moves on low volume, technical resets, or undisclosed developments.

The absence of any news in the Yahoo Finance RSS feed over the past two days means this decline cannot be attributed to a specific announced event like earnings, guidance, regulatory action, or corporate development. UZX is a penny stock trading at $0.10, which typically exhibits high volatility and can move sharply on minimal trading volume, technical chart breaks, or sentiment shifts that may not generate broad media coverage. The stock's ranking as the 35th biggest loser suggests it was among the day's more active price movers, but without accompanying headlines, the catalyst remains opaque. Possible explanations include delayed earnings disappointment, broker downgrades, social media or message-board sentiment reversals, sector rotation out of micro-caps, or simple technical selling at a resistance level, but none of these are confirmed by available evidence.

BNC

CEA Industries Inc.Industrials

$4.43−$0.81

-15.5%

NASDAQ · Mkt cap $108 M

No news headlines were found in the last 48 hours for BNC, so the 15.47% drop likely reflects a market reaction to an unannounced event, technical selling, or delayed news not yet indexed by the RSS feed.

With no recent headlines available, we cannot identify a specific catalyst from the news record. A 15% single-day drop on a micro-cap stock like BNC (trading at $4.43) could stem from several sources typical of this category: a negative earnings or guidance announcement not yet indexed, insider selling or dilution news, analyst downgrade, sector rotation out of small-cap equities, technical breakdown below a key support level, or short-squeeze unwind. Given the rank as 36th biggest loser, this appears to be a material but not unique event for the market on this date. Without access to real-time filings, press releases, or trading data beyond the price snapshot, the root cause remains unknown from the evidence provided.

MODD

Modular Medical, Inc.Healthcare

$2.83−$0.51

-15.4%

NASDAQ · Mkt cap $13 M

No material news explaining the 15.41% drop was provided; the two headlines merely announce MODD's participation in an investor conference on September 15-16, which is forward-looking and not negative.

The available headlines contain only a conference participation announcement dated September 8, 2026, which is neither bullish nor bearish and does not explain a sharp single-day decline. This is a pre-event notice with no substance tied to company performance, product approvals, clinical outcomes, financial results, or guidance. For a commercial-stage medical device company trading at a modest price point, typical drivers of sharp single-day losses include: clinical trial setbacks or delays, regulatory hurdles or FDA feedback, loss of a key partnership or customer, competitive threats, insider selling signals, short-seller reports, or broader market liquidation in small-cap healthcare. Without access to those categories of information, the cause remains opaque. The conference participation itself is immaterial and does not account for the magnitude of the decline.

SKIL

Skillsoft Corp.Consumer Defensive

$6.30−$1.02

-15.3%

NYSE · Mkt cap $71 M

Skillsoft beat earnings estimates by 41% but missed revenue expectations slightly, and the market appears to have reacted negatively to the revenue miss and likely cautious forward guidance despite the earnings beat.

Skillsoft reported Q2 fiscal 2027 results on September 9, 2026, delivering a substantial earnings surprise of +40.96% but a slight revenue miss of -0.40%. While an earnings beat of that magnitude would normally support a stock, the revenue shortfall combined with the company's modest top-line growth trajectory appears to have dominated market sentiment. The 15% single-day drop suggests investors are interpreting the results as evidence of either slowing demand for the company's AI-native skills management platform, margin expansion masking underlying business weakness, or potentially cautious forward guidance that was not detailed in these headlines. For a software/SaaS company like Skillsoft, revenue growth is often weighted more heavily than bottom-line profitability in valuation, so a revenue miss—even if small—can trigger significant repricing, particularly if accompanied by guidance concerns.

VIRI

Virios Therapeutics, LLC

$1.94−$0.35

-15.3%

GRAN

Grande Group LimitedFinancial Services

$1.01−$0.18

-15.1%

NASDAQ · Mkt cap $31 M

No news headlines were found in the last 48 hours, so the 15% drop cannot be tied to a specific announced event; the decline may reflect technical selling, sector rotation, or undisclosed company developments.

The absence of any news in the Yahoo Finance RSS feed over the last two days means we cannot identify a concrete catalyst for the 15.13% drop in GRAN stock. Without knowing the company's sector, market cap, recent earnings history, or insider activity, attributing the move to a particular cause would be speculation. Stocks at this price level sometimes experience sharp moves due to technical support breaks, changes in short interest, insider selling, delayed press releases not yet indexed by major feeds, or broader market sector rotation. Without access to trading volume, short data, or company-specific fundamentals, the specific trigger remains unknown.

XTND

Xtend AI Robotics Inc

$4.81−$0.84

-14.9%

CLIK

Click Holdings LimitedConsumer Cyclical

$1.15−$0.20

-14.8%

NASDAQ · Mkt cap $12 M

No news headlines were found in the last 48 hours for CLIK, so the 14.78% drop likely stems from technical selling, a delayed announcement, or general market conditions affecting micro-cap stocks on this date.

The absence of any news in the Yahoo Finance RSS feed over the past two days makes it difficult to pinpoint a specific catalyst for the sharp 14.78% decline. CLIK is a micro-cap stock, and these securities are prone to outsized moves driven by illiquidity, algorithmic selling, or sector-wide weakness that may not generate immediate headline coverage. The stock could have declined on an unannounced earnings miss, insider selling, a sector rotation, or simply technical breakdown if it had rallied previously. Without headlines or structural context about the company's fundamentals, business model, or recent performance trajectory, we cannot distinguish between routine volatility and a material event that has not yet surfaced in financial media.

CURX

CURANEX PHARMACEUTICALS INCHealthcare

$4.20−$0.78

-14.8%

NASDAQ · Mkt cap $7.7 M

No news headlines were published in the last 48 hours for CURX, so the 14.77% decline cannot be directly attributed to a specific announced event; the drop likely reflects either delayed market reaction to prior news, broader biotech sector weakness, or unannounced developments.

The absence of recent news makes it impossible to point to a definitive catalyst for today's 14.77% loss. For a small-cap pharmaceutical stock like Curanex, typical drivers of sharp single-day declines include clinical trial setbacks, FDA rejection letters, pipeline delays, dilutive financing announcements, or sector-wide selloffs in biotech. Without headlines, we cannot distinguish between these possibilities. It is also possible the market is reacting to news that has not yet been indexed by Yahoo Finance, or to rumors circulating on trading platforms not captured in major news feeds. The stock's ranking as the 43rd biggest loser suggests this was a meaningful move driven by something material rather than random noise, but the evidence does not establish what that something was.

YDES

YD BIO LIMITEDHealthcare

$3.93−$0.67

-14.6%

NASDAQ · Mkt cap $317 M

No news headlines were available in the last 48 hours, so the 14.56% decline cannot be attributed to any reported event. The drop likely reflects either a delayed market reaction to an earlier announcement, broad biotech sector weakness, technical selling, or unvetted rumors.

YD BioLimited experienced a significant single-day loss of 14.56% on September 9, 2026, but the absence of recent news in the RSS feed means no specific catalyst can be identified from public reporting. For a biotech company of this size, typical catalysts for sharp declines include clinical trial results, regulatory setbacks, funding announcements, or sector-wide pressure. The move could stem from a news event that occurred before the 48-hour window, an internal corporate action not yet widely reported, analyst downgrade, or broader market sentiment affecting small-cap biotechs. Without confirmed headlines tied to the move, the underlying driver remains speculative.

CHRN

ChronoScale CorporationTechnology

$18.08−$3.06

-14.5%

NASDAQ · Mkt cap $2.9 B

No financial news was reported for ChronoScale in the last 48 hours, so the 14.48% decline likely stems from broad market weakness, sector rotation, or undisclosed company developments not yet covered by major financial media.

The absence of any headlines in the Yahoo Finance RSS feed over the past 48 hours means we cannot attribute the sharp 14.48% drop to a specific announced event such as earnings disappointment, guidance reduction, regulatory action, or management departure. The stock's ranking as the 45th biggest loser suggests this was a notable but not market-shaking move. Without news, the decline could reflect several generic categories: systematic sector rotation away from whatever segment ChronoScale operates in, technical selling or stop-loss triggers following a prior run-up, broader market weakness on the day of snapshot, or an unannounced development that has not yet reached mainstream financial news outlets. Small-cap and mid-cap stocks often experience sharp moves on limited trading volume or on information asymmetries before formal disclosure.

NOTE

FiscalNote Holdings, Inc.Technology

$0.05−$0.01

-14.3%

NYSE · Mkt cap $2.0 M

No headlines are available in the last 48 hours to explain the 14.34% drop in NOTE stock. The decline likely reflects either broad market weakness, sector-specific selling pressure, or delayed negative news not yet captured in headlines.

FiscalNote Holdings (NOTE) dropped 14.34% on September 9, 2026, to $0.05 per share, ranking 46th among daily losers. However, no news headlines from the prior 48 hours are available to identify a specific catalyst. At this price level, the stock may be highly sensitive to liquidity events, technical breakdowns, or microstructure dynamics typical of sub-penny equities. For a government relations and legislative data software company like FiscalNote, potential causes could include quarterly earnings disappointment, guidance reduction, customer churn, or broader selloff in SaaS valuations, but these remain hypotheses without headline confirmation. Alternatively, delayed announcements or analyst downgrades may not yet be reflected in the RSS feed.

TRBG

TURBOGEN LTD

$4.49−$0.75

-14.3%

CASY

Casey's General Stores IncConsumer Cyclical

$629.02−$104.66

-14.3%

NASDAQ · Mkt cap $28 B

Casey's reported strong earnings with EPS up 28%, but inside same-store sales growth of 3.2% disappointed investor expectations, prompting a sharp 14% sell-off despite beating on the bottom line.

The headline consensus is clear: Casey's delivered a solid quarter with earnings beating estimates, record prepared food sales, and improved fuel profitability. However, the market's reaction was sharply negative because inside same-store sales growth of 3.2% fell short of what investors were anticipating. Multiple sources note that after the stock's recent strong run-up, the market was demanding growth acceleration rather than mere earnings beats. The disconnect appears to be between headline earnings strength and underlying comparable sales weakness in the core business. Analysts described results as "effective execution amid uneven macro" conditions, suggesting macro headwinds may be restraining same-store sales momentum despite the company's operational improvements.

HPAI

Helport AI Limited Ordinary SharesTechnology

$0.30−$0.06

-14.2%

NASDAQ · Mkt cap $16 M

No news headlines were reported in the last 48 hours for HPAI, so the 14.21% decline cannot be directly attributed to any announced event; the cause remains unknown without additional context.

HPAI dropped 14.21% to $0.30 with zero news coverage in the preceding 48 hours according to the available RSS feed. This absence of headlines makes it impossible to point to a specific corporate announcement, earnings report, regulatory action, or partnership as the direct trigger. For a micro-cap stock trading at $0.30, common drivers of such moves typically include delayed financial disclosures, insider trading activity, short-seller reports, technical support breakdown, or sector-wide weakness. Without access to broader market context, SEC filings, or real-time trading data for that date, we cannot determine which category applies. The lack of news coverage could also indicate the move occurred but lacked immediate press pickup, or that the catalyst was non-public information.

HAO

Invesco China Small Cap ETFCommunication Services

$2.91−$0.48

-14.2%

NASDAQ · Mkt cap $1.4 M

No news headlines were published in the last 48 hours, so the 14.16% drop cannot be attributed to a specific announced event. The decline likely reflects broad market weakness in Chinese equities or sector-specific selling pressure.

HAO is an inverse or leveraged China-focused small-cap ETF, making it highly sensitive to shifts in sentiment toward Chinese equities and small-cap valuations. Without any news headlines in the window provided, the sharp decline was not triggered by a named catalyst such as earnings, regulatory action, or company-specific events. This type of move in a China-focused fund is typically driven by macroeconomic concerns, geopolitical developments, currency headwinds, or broad risk-off sentiment in equities. ETFs can also experience disproportionate moves due to rebalancing, options expiry effects, or tracking errors if the underlying index had an outsized move. The absence of any accompanying news suggests either that the move was driven by overnight or pre-market developments not yet captured in headline feeds, or that it represents a delayed response to information released more than 48 hours prior.